SKYCLARYS 50 mg, hard capsule 90 capsules
Active ingredients: OMAVÉLOXOLONE
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule90 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SKYCLARYS 50 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 90 gélule(s)
- Marketing authorisation holder
- BIOGEN NETHERLANDS (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
63167621CIP73028510CIP133400930285107Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OMAVÉLOXOLONEgélule | 50 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.